Matalon, S., Palmer, B. E., Nold, M. F., Furlan, A., Kassu, A., Fossati, G., . . . Dinarello, C. A. (2010). The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro.

Matalon, Shay, Brent E. Palmer, Marcel F. Nold, Antonio Furlan, Afework Kassu, Gianluca Fossati, Paolo Mascagni, and Charles A. Dinarello. The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression On CD4+ T-Cells and Monocytes and Is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro. 2010.

Matalon, Shay, et al. The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression On CD4+ T-Cells and Monocytes and Is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro. 2010.